Regeneron and Lilly post new data backing COVID antibody cocktails
pharmaphorum
JANUARY 27, 2021
Regeneron is considering an emergency filing for its antibody cocktail REGEN-COV to protect people against COVID-19 after early trial results showed it conferred 100% protection against symptomatic infection. The post Regeneron and Lilly post new data backing COVID antibody cocktails appeared first on.
Let's personalize your content